A Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid Tumors
Actym Therapeutics, Inc.
Actym Therapeutics, Inc.
Shanghai Bao Pharmaceuticals Co., Ltd.
Pfizer
Carisma Therapeutics Inc
Celldex Therapeutics
Xencor, Inc.
MacroGenics
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Duke University
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
NYU Langone Health
Case Comprehensive Cancer Center